IMMUNOSUPPRESSIVE AGENTS
Clinical trials for IMMUNOSUPPRESSIVE AGENTS explained in plain language.
Never miss a new study
Get alerted when new IMMUNOSUPPRESSIVE AGENTS trials appear
Sign up with your email to follow new studies for IMMUNOSUPPRESSIVE AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could cutting immune drugs save kidney transplants during severe infections?
Disease control Recruiting nowThis study tests whether reducing immunosuppressive drugs (along with giving a steroid) helps kidney transplant patients recover from septic shock or severe breathing failure in the ICU. About 212 adults whose transplant was at least 3 months ago will be randomly assigned to eith…
Matched conditions: IMMUNOSUPPRESSIVE AGENTS
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: IMMUNOSUPPRESSIVE AGENTS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC